Attention should be paid to the dose of propofol during target-controlled infusion

摘要

Target-controlled infusion (TCI) is useful for anesthetic management using propofol because a TCI system can automatically adjust the dose to keep the predicted concentration of propofol at the target concentration that was input into the TCI system by an anesthesiologist. However, human error such as inputting incorrect weight can cause administration of propofol at an inappropriate dose. Therefore, attention should be paid to whether the dose is appropriate or inappropriate against a target concentration. We calculated the dose of propofol during TCI with 3 μg/mL of the target propofol concentration and found that the dose converged to 4.884 (mg/kg/h) and that the dose can be calculated in many periods by multiplying the target concentration (μg/mL) by 1.7-2.3. Since the concentration of propofol depends on only the dose independent of personal characteristics, the dose that should be administered (mg/kg/h) can be estimated by doubling the target concentration (μg/mL) and we should therefore repeatedly confirm that the appropriate dose is being administered. Financial Support/ Disclosure Takayuki Kunisawa has received speaker's honoraria from AstraZeneca K.K.(Osaka, Japan). Takayuki Kunisawa was supported by AstraZeneca K.K.(Osaka Japan) for scientific research on pharmacokinetics simulation.Presentation at the conferencePresented at The Annual Meeting of Japanese Society of Anesthesiologists, Yokohama, June 12, 2008. To the editor A target-controlled infusion (TCI) system is very convenient because a syringe pump with a built-in DiprifusorTM (AstraZeneca, London, UK) can adjust the propofol dose by means of just inputting the expected target concentration of propofol during anesthetic management after inputting the patient’s characteristics such as weight and age before starting administration. However, confirmation of matching dose with predicted plasma concentration (Cp) displayed on the syringe pump is thought to be always necessary for preventing human errors such as inputting incorrect weight. We calculated the predicted Cp using TIVAtrainerTM (available at: http://www.eurosiva.org/; accessed on May 1, 2010) with Marsh’s parameter [1] when it was assumed that propofol was administered using TCI with 3 μg/mL of the target concentration in a 40-year-old male with a height of 170 cm and weight of 70 kg (Figure 1). The dose converged to approximately 4.884 mg/kg/h under the above conditions.